| Disease | THE PURPOSE OF THIS STUDY WAS TO EXAMINE THESE CLAIMS, WITH SPECIFIC REFERENCE TO GINSENG'S EFFECTS ON AFFCT AND MOOD. PROSPECTIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL. EIGHTY-THREE ADULTS (40 WOMEN, 43 MEN) PARTICIPATED
IN THIS STUDY (MEAN GAGE=25.7 YEAR). PARTICIPANTS WERE RECRUITED FROM WITHIN A UNIVERSITY COMMUNITY AND AT AREA HEALTH CLUBS. PARTICIPANTS WERE RANDOMLY ASSIGNED TO ONE OF THREE EXPERIMENTAL CONDITIONS: PLACEBO (LACTOSE), 200 MG GINSENG
OR 400 MG GINSENG. THE GINSENG PREPARATION USED IN THIS STUDY CONSISTED OF THE PANAX GINSENG C A MEYER CONCENTRATE G115 IN CAPSULAR FORMAT. EACH PARTICIPANT WAS GIVEN A 60-DAY ALLOTMENT OF THEIR RESPECTIVE SUPPLEMENT ALONG WITH WRITTEN
INSTRUCTIONS ABOUT THE PROPER INTAKE AND STORAGE OF THE CAPSULES DURING THE 8-WEEK STUDY PERIOD. POSITIVE AFFECT, NEGATIVE AFFECT, AND TOTAL MOOD DISTURBANCE. MEASURES WERE OBTAINED PRE- AND POST-INTERVENTION. GINSENG SUPPLEMENTATION
HAD NO EFFECT ON POSITIVE AFFECT, NEGATIVE AFFECT, OR TOTAL MOOD DISTURBANCE (ALL P>0.16). THE PRESENT FINDINGS DO NOT SUPPORT CLAIMS THAT CHRONIC GINSENG SUPPLEMENTATION---AT EITHER ITS CLINICALLY RECOMMENDED LEVEL OR AT TWICE THAT LEVEL---
ENHANCES AFFECT OR MOOD IN HEALTHY YOUNG ADULTS. |